KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pvh (PVH) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Pvh (PVH) over the last 16 years, with Nov 2025 value amounting to $158.2 million.

  • Pvh's Cash & Equivalents fell 71.73% to $158.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $158.2 million, marking a year-over-year decrease of 71.73%. This contributed to the annual value of $748.0 million for FY2025, which is 5.71% up from last year.
  • According to the latest figures from Q4 2025, Pvh's Cash & Equivalents is $158.2 million, which was down 36.41% from $248.8 million recorded in Q3 2025.
  • Pvh's 5-year Cash & Equivalents high stood at $1.7 billion for Q1 2021, and its period low was $137.3 million during Q2 2025.
  • For the 3-year period, Pvh's Cash & Equivalents averaged around $433.4 million, with its median value being $375.0 million (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 2,009.01% in 2021, then plummeted by 71.73% in 2025.
  • Pvh's Cash & Equivalents (Quarterly) stood at $1.3 billion in 2021, then tumbled by 64.81% to $457.0 million in 2022, then declined by 21.75% to $357.6 million in 2023, then skyrocketed by 56.49% to $559.6 million in 2024, then tumbled by 71.73% to $158.2 million in 2025.
  • Its Cash & Equivalents stands at $158.2 million for Q4 2025, versus $248.8 million for Q3 2025 and $137.3 million for Q2 2025.